Using Technology for Better Health: Lessons from AI and Robotics for Mesothelioma Patients

Using Technology for Better Health: Lessons from AI and Robotics for Mesothelioma Patients

ByHolly Zink

The healthcare field is changing fast with the use of artificial intelligence (AI) and robotics, leading to better patient care. Vietnam’s healthcare system is using these technologies more and more, setting an example for other countries.  A new article from the Cureus Journal of Medical Science looks at how AI and robotics are advancing in Vietnam and how these innovations could help mesothelioma patients in the future. The Role of AI in Healthcare AI is transforming healthcare by improving how medical data is analyzed and used for decision-making. In Vietnam, AI technologies like text mining and machine learning are being used to process large amounts of medical data. This helps in making accurate diagnoses and creating personalized treatment plans.  AI’s…

Using Decision Tools for Mesothelioma: Enhancing Shared Decision-Making

Using Decision Tools for Mesothelioma: Enhancing Shared Decision-Making

ByHolly Zink

Mesothelioma, caused by asbestos exposure, is a rare and aggressive cancer. It often presents many challenges in diagnosis, treatment, and patient management. With advances in medical technology and data analytics, decision tools are becoming crucial for helping clinicians make informed decisions.  A new article from the Society for Medical Decision-Making explores decision tools, how clinicians use them, and their role in enhancing shared decision-making for patients with mesothelioma. What Are Decision Tools? Decision tools are software or algorithms that help healthcare providers make clinical decisions by combining patient-specific data with evidence-based guidelines and predictive models.  These tools analyze various factors, like medical history, clinical findings, and risk factors, to give recommendations or predict outcomes. They come in many forms, such…

Managing Mesothelioma: Vital Tips for Older Adults and Their Caregivers

Managing Mesothelioma: Vital Tips for Older Adults and Their Caregivers

ByHolly Zink

Mesothelioma is a rare and aggressive cancer caused by exposure to asbestos. It most often affects the lining of the lungs (pleural mesothelioma), but it can also impact the lining of the abdomen, heart, or testicles. Older adults, especially those who worked in industries with high asbestos exposure, are at greater risk. A new article from the Australasian Journal on Ageing provides important information for elderly Americans and their caregivers on understanding and managing mesothelioma. What is Mesothelioma? Mesothelioma is a cancer that develops in the thin layer of tissue covering most internal organs. The most common type, pleural mesothelioma, affects the tissues around the lungs. The leading cause is asbestos exposure. When asbestos fibers are inhaled or swallowed, they…

The Role of Surgery in Pleural Mesothelioma
|

The Role of Surgery in Pleural Mesothelioma

ByHolly Zink

Pleural Mesothelioma is a rare and aggressive cancer caused by asbestos exposure. The outlook for this disease is often poor, with a typical survival time of 9 to 20 months after treatment. The overall 5-year survival rate is around 5%. However, new treatments that include surgery are helping improve these numbers. A new article from Cancers explains how surgery helps in diagnosing, staging, and treating pleural mesothelioma. Importance of Surgery in Diagnosis and Staging Surgery is very important for diagnosing and staging pleural mesothelioma accurately. During surgery, doctors can take tissue samples to confirm the disease and identify its type. Correct staging, which means figuring out how far the disease has spread, is crucial for planning the right treatment.  Major…

Understanding Mesothelioma Classification and Staging: Insights from the IASLC Mesothelioma Staging Project

Understanding Mesothelioma Classification and Staging: Insights from the IASLC Mesothelioma Staging Project

ByHolly Zink

Malignant pleural mesothelioma is a rare, aggressive cancer linked to asbestos. Proper classification and staging are key. They guide treatment and predict outcomes. The TNM system by the IASLC is crucial. It categorizes cancers based on their size and spread. The IASLC Mesothelioma Staging Project now aims to improve the ‘N’ descriptors for the 9th edition. A new article discusses mesothelioma staging, focusing on suggested changes for ‘N’ descriptors. The TNM Classification System The TNM classification system is a universally accepted standard for staging cancer, including pleural mesothelioma. It categorizes cancer based on three key components: T (Tumor): Refers to the size and extent of the primary tumor. N (Node): Indicates whether the cancer has spread to regional lymph nodes….

Mesothelioma Prognosis and Survival Rates: Women and Extended Pleurectomy Decortication

Mesothelioma Prognosis and Survival Rates: Women and Extended Pleurectomy Decortication

ByHolly Zink

Malignant pleural mesothelioma is a fast-spreading cancer tied to asbestos. Sadly, patients on standard treatments survive just 12–18 months. However, recent studies show better outcomes for some, especially women. They receive ePD surgery, part of a combined treatment. Now, a new article examines mesothelioma patient outcomes. It looks at the factors impacting survival and the benefits of specific treatments. Understanding Pleural Mesothelioma and the Pleural Space Pleural mesothelioma is a cancer in the pleura, the thin membrane around the lungs and chest. It’s mainly caused by asbestos exposure, from work or the environment. This cancer affects the pleural space, crucial for lung movement during breathing. A tumor or pleural effusion, excess fluid, can harm breathing and worsen mesothelioma symptoms. Clinical…

MARS 2 Trial: The Future of Pleurectomy Decortication in Pleural Mesothelioma

MARS 2 Trial: The Future of Pleurectomy Decortication in Pleural Mesothelioma

ByHolly Zink

Malignant pleural mesothelioma, a deadly cancer, often comes from asbestos exposure. It is hard to treat due to its aggressiveness and the challenges of full surgical removal. The MARS 2 trial investigated if extended pleurectomy decortication (P/D) could boost survival and life quality in patients with resectable mesothelioma. A new article looks into the MARS 2 trial’s results, explains clinical trials, and suggests why mesothelioma patients should join them. Understanding Clinical Trials Clinical trials are research studies conducted to evaluate new medical treatments, drugs, or procedures in humans. These trials are essential for advancing medical knowledge and improving patient care. Clinical trials are typically divided into several phases: Phase I: Tests the safety and dosage of a new treatment in…

Leveraging the Pleural Space for Anticancer Therapies in Pleural Mesothelioma

Leveraging the Pleural Space for Anticancer Therapies in Pleural Mesothelioma

ByHolly Zink

Malignant pleural mesothelioma is a cancer caused by asbestos. It’s deadly and spreads quickly. It usually appears 30-50 years after inhaling asbestos. Sadly, most patients survive only 18 months. Although rare, cases are growing. In 2020, over 30,000 cases were reported worldwide. This number is expected to reach 53,000 by 2040. The rise is due to ongoing asbestos use and its presence in banned areas. What is Pleural Mesothelioma? The pleural space is a thin gap filled with fluid between two pleura layers. These layers line the lungs and chest wall. This space is crucial for lung function. It helps the lungs expand and contract smoothly during breathing. However, it can also be a site for diseases like fluid build-up…

Understanding Ex-Vivo Models in Mesothelioma Research

Understanding Ex-Vivo Models in Mesothelioma Research

ByHolly Zink

Malignant pleural mesothelioma is a deadly cancer caused by asbestos exposure. New cancer research gives patients and caregivers hope and clarity on treatments. One key tool in this research is ex-vivo models. These include precision-cut tumor slices (PCTS). A new article highlights ex-vivo models and PCTS, and their importance in mesothelioma research and treatment. What Does Ex-Vivo Mean? “Ex-vivo” refers to studies on living tissues outside the body. These studies closely mimic the body’s natural environment. Unlike “in-vivo” (inside the body) or “in-vitro” (in a petri dish), “ex-vivo” models maintain the tissue’s complexity. This allows researchers to study cancer cell interactions with their environment more realistically. Precision-Cut Tumor Slices (PCTS) in Cancer Research PCTS are ex-vivo models with thin slices…

Malignant Pleural Mesothelioma: Timeline and Analysis of 70 Cases

Malignant Pleural Mesothelioma: Timeline and Analysis of 70 Cases

ByHolly Zink

Malignant pleural mesothelioma is a severe cancer linked to asbestos exposure. It often appears decades after exposure. The disease’s early symptoms are unclear, making it hard to diagnose early. Despite being rare, this cancer is a major health concern. It has a poor prognosis and few treatment options. A new article details the study of 70 cases at Getafe University Hospital from 2008 to 2021. Study Overview The study aimed to detail key aspects of malignant pleural mesothelioma. It covered clinical, histological, radiological, and treatment features. The hospital’s Ethics and Research Committee approved it. The sample involved 70 patients, mainly elderly males with an average age of 71. Asbestos exposure was found in 61% of cases. Common symptoms were shortness…